Xintian Wang

406 citations
12 papers · 285 indexed · h-index 8
Topics
Hepatocellular Carcinoma Treatment and Prognosis (3 papers)Pancreatic and Hepatic Oncology Research (2 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers)
Partner nations
ChinaUnited States

In The Last Decade

Xintian Wang

10 papers receiving 282 citations

Peers

Xintian Wang
Comparison fields: 5 of 59
  • Oncology 199
  • Organic Chemistry 105
  • Inorganic Chemistry 56
  • Molecular Biology 46
  • Pulmonary and Respiratory Medicine 36
Replace Wenjiao Zhu with:
Wenjiao Zhu China
Hiroshi Sonoda Japan
JoLyn Turner United States
Keigo Hayashi Japan
Kenneth J. Wiggall United States
Linyan Xu China
N. Patel United States
Rakesh Agarwal India
Francesco Bartoli Italy
Xintian Wang relative to Wenjiao Zhu China Wenjiao Zhu's profile →
Citations per field
00.5×4.5×
Wenjiao Zhu · 1×
Citations per year

Countries citing papers authored by Xintian Wang

Since Specialization
Citations

This map shows the geographic impact of Xintian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xintian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xintian Wang more than expected).

Fields of papers citing papers by Xintian Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xintian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xintian Wang. The network helps show where Xintian Wang may publish in the future.

Co-authorship network of co-authors of Xintian Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xintian Wang. A scholar is included among the top collaborators of Xintian Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xintian Wang. Xintian Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 32
2 0
3 17
4 20
5 10
6 14
7 0
8 162
9 8
10 13
11 6
12
[Effects of electroacupuncture anesthesia of different frequencies on stress reaction in thyroid surgery].
3

About Xintian Wang

Xintian Wang is a scholar working on Hepatology, Oncology and Complementary and alternative medicine, having authored 12 papers that have together received 285 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Oncology (199 citations), Inorganic Chemistry (56 citations) and Organic Chemistry (105 citations). Xintian Wang has collaborated with scholars based in China and United States. Frequent co-authors include Cheng‐Zhi Xie, Jing‐Yuan Xu, Xueqing Song, Xin Qiao, He Tian, Hongchao Li, Ting Zhou, Jingxian Gu, Lan Yang and Jun Fang. Their work appears in journals such as Molecular Cancer, Medicine and Dalton Transactions.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026